E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/6/2019 in the Prospect News High Yield Daily.

Mallinckrodt mixed on settlement news; PG&E better in run-up to restructuring plan

By James McCandless

San Antonio, Sept. 6 – At the end of the week, the distressed space was subdued with focus on the pharmaceuticals and utilities space.

Mallinckrodt plc’s notes varied in direction after the company announced a settlement with two Ohio counties over opioid-related claims.

The 4 7/8% senior notes due 2020 added 4½ points to close at 62 bid. The 5¾% senior notes due 2022 lost 2¼ points to close at 36 bid.

The Staines-upon-Thames, England-based drug manufacturer announced that it had reached an agreement to pay two Ohio counties, Summit and Cuyahoga, $24 million in cash to settle lawsuits related to the opioid epidemic.

Sector peer Endo International plc’s issues were positive on news that it had finalized a similar settlement agreement in Ohio.

Meanwhile, in utilities, PG&E Corp.’s notes performed better despite unfavorable developments from the California legislature.

The 6.05% notes due 2034 rose ¼ point to close at 108½ bid.

The San Francisco-based bankrupt electric utility was under pressure for most of the day but saw some relief in the afternoon despite unfavorable developments in the California legislature.

A bill that would have let the company use future profits to finance up to $20 billion in bonds dedicated to covering wildfire liabilities died before being considered.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.